Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119251 | 1.00 | UGT2B7 (0.63) | UGT2B7SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL29756087 | 1.00 | UGT2B7 (0.63) | UGT2B7SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL3296875 | 1.00 | UGT2B7 (0.63) | UGT2B7SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL27938398 | 0.91 | UGT2B7 (0.48) | UGT2B7SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL29555341 | 0.83 | UGT2B7 (0.71) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL599956 | 0.83 | UGT2B7 (0.71) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| Naphthalene SCHEMBL9636781 | 0.83 | UGT2B7 (0.71) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL9179436 | 0.83 | UGT2B7 (0.71) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL30928206 | 0.83 | UGT2B7 (0.71) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| Naphthalene SCHEMBL29078859 | 0.83 | UGT2B7 (0.71) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741513-B2 | Thioacids and thioacid salts for determining the enantiomeric excess of chiral compounds containing an electrophilic carbon center | RICHMAN JACK E | 2010-06-22 | — | — | US | disclosed |
| US-20090181462-A1 | Thioacids and thioacid salts for determining the enantiomeric excess of chiral compounds containing an electrophilic carbon center | RICHMAN JACK E | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181462-A1 | Thioacids and thioacid salts for determining the enantiomeric excess of chiral compounds containing an electrophilic carbon center | TST, SLC6A6, MPST | UGT2B7 444/4885SLC6A2 420/4885SLC6A4 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.